WORTMANNIN (cas 19545-26-7) potentiates the combined effect of etoposide and cisplatin in human glioma cells
-
Add time:08/25/2019 Source:sciencedirect.com
The combination of etoposide and cisplatin represents a common modality for treating of glioma patients. These drugs directly and indirectly produce the most lethal DNA double-stand breaks (DSB), which are mainly repaired by non-homologous DNA end joining (NHEJ). Drugs that can specifically inhibit the kinase activity of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), the major component of NHEJ, are of special interest in cancer research. These small molecule inhibitors can effectively enhance the efficacy of current cancer treatments that generate DNA damage. In this study, we investigated the effect of DNA-PKcs inhibitor, WORTMANNIN (cas 19545-26-7), on the cytotoxic mechanism of etoposide and cisplatin in MO59K and MO59J human glioblastoma cell lines. These cell lines are proficient and deficient in DNA-PKcs, respectively. Wortmannin synergistically increased the cytotoxicity of cisplatin and etoposide, when combined, in NHEJ-proficient MO59K cells. Surprisingly, wortmannin sensitizing effect was also observed in DNA-PKcs-deficient MO59J cells. These data suggest that wortmannin sensitization to etoposide and cisplatin in human glioma cells is mediated by inhibition of not only DNA-PKcs activity but other enzymes from PI3-K family, e.g. ATM and ATR. A concentration-dependent increase in etoposide and cisplatin-induced DSB levels was potentiated by inhibitor in both cell lines. Moreover, drug-induced accumulation in the G2/M checkpoint and S-phase was increased by wortmannin. Wortmannin significantly inhibited drug-induced DSB repair in MO59 cells and this effect was more pronounced in MO59J cells. We conclude that the mechanism of wortmannin potentiation of etoposide and cisplatin cytotoxicity involves DSBs induction, DSBs repair inhibition, G2/M checkpoint arrest and inhibition of not only DNA-PKcs activity.
We also recommend Trading Suppliers and Manufacturers of WORTMANNIN (cas 19545-26-7). Pls Click Website Link as below: cas 19545-26-7 suppliers
Prev:Inhibition of tomato fruit ripening by 1-MCP, WORTMANNIN (cas 19545-26-7) and hexanal is associated with a decrease in transcript levels of phospholipase D and other ripening related genes
Next:Prevention of the WORTMANNIN (cas 19545-26-7)-induced inhibition of phosphoinositide 3-kinase by sulfhydryl reducing agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Differential effects of LY294002 and WORTMANNIN (cas 19545-26-7) on inducible nitric oxide synthase expression in glomerular mesangial cells08/30/2019
- Inhibition of WORTMANNIN (cas 19545-26-7) activities by amino compounds08/29/2019
- Effects of WORTMANNIN (cas 19545-26-7), sodium nitroprusside, insulin, genistein, and guanosine triphosphate on chemotaxis and cell growth of Entodinium caudatum, Epidinium caudatum, and mixed ruminal protozoa08/28/2019
- Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid WORTMANNIN (cas 19545-26-7) against multidrug-resistant tumor cells08/27/2019
- Prevention of the WORTMANNIN (cas 19545-26-7)-induced inhibition of phosphoinositide 3-kinase by sulfhydryl reducing agents08/26/2019
- Inhibition of tomato fruit ripening by 1-MCP, WORTMANNIN (cas 19545-26-7) and hexanal is associated with a decrease in transcript levels of phospholipase D and other ripening related genes08/24/2019
- Pretreatment with WORTMANNIN (cas 19545-26-7) alleviates lipopolysaccharide/d-galactosamine-induced acute liver injury08/23/2019
- CommunicationIntracellular effects of prodrug-like WORTMANNIN (cas 19545-26-7) probes08/22/2019


